(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 29.37% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Seer's revenue in 2025 is $15,309,000.On average, 2 Wall Street analysts forecast SEER's revenue for 2025 to be $1,025,083,215, with the lowest SEER revenue forecast at $1,017,665,741, and the highest SEER revenue forecast at $1,032,559,559. On average, 2 Wall Street analysts forecast SEER's revenue for 2026 to be $1,380,533,308, with the lowest SEER revenue forecast at $1,344,741,049, and the highest SEER revenue forecast at $1,416,384,435.
In 2027, SEER is forecast to generate $1,994,358,765 in revenue, with the lowest revenue forecast at $1,863,552,189 and the highest revenue forecast at $2,125,165,341.